Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients

Anti-drug antibodies can interfere with the activity of anti-tumor necrosis factor (TNF) agents by increasing drug clearance via direct neutralization. The presence of anti-drug antibodies is clinically relevant when trough drug concentrations are undetectable or sub-therapeutic. However, traditiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Facchin, Sonia, Buda, Andrea, Cardin, Romilda, Agbariah, Nada, Zingone, Fabiana, De Bona, Manuela, Zaetta, Debora, Bertani, Lorenzo, Ghisa, Matteo, Barberio, Brigida, Savarino, Edoardo Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989110/
https://www.ncbi.nlm.nih.gov/pubmed/33815569
http://dx.doi.org/10.1177/1756284821999902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989110/
https://www.ncbi.nlm.nih.gov/pubmed/33815569
http://dx.doi.org/10.1177/1756284821999902

Ejemplares similares